$OMER Please note that I have written this report to provide a brief overview of the company to potential Omeros investors so that it may serve as a start of due diligence. Too few investors have even heard of the company, IMO. OMEROS BASICS: UNDERVALUED COMMERCIAL BIOTECH ON THE MOVE Alan Robert Ross Trust Intelligence November 27, 2019 trustintelligence.com/forum...
  • 45
  • 12